Embolix

Embolx is a medical device company that develops and commercializes microcatheters for use in interventional radiology and oncology procedures. Its flagship product, the Sniper Balloon Occlusion Microcatheter, is designed to improve the delivery of therapeutic agents to cancerous tumors while protecting healthy tissue. By utilizing pressure-controlled embolization, the technology enhances drug uptake and reduces non-target embolization in procedures such as chemoembolization and radioembolization. The company's solutions are primarily applied in the treatment of liver cancer, including hepatocellular carcinoma and metastatic disease, as well as in prostatic artery embolization. Embolx was acquired by Edwards Lifesciences in 2022 to strengthen its portfolio in the interventional oncology space.